| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE)
|
Kasatkar, Priyanka
|
|
2013
|
93 |
1 |
p. 173-175
|
artikel
|
| 2 |
A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myeloma
|
Berenson, James R.
|
|
2013
|
93 |
1 |
p. 89-98
|
artikel
|
| 3 |
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes
|
Pantani, Lucia
|
|
2013
|
93 |
1 |
p. 123-128
|
artikel
|
| 4 |
Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH)
|
Aurer, Igor
|
|
2013
|
93 |
1 |
p. 177-178
|
artikel
|
| 5 |
DCEP for relapsed or refractory multiple myeloma after therapy with novel agents
|
Park, Silvia
|
|
2013
|
93 |
1 |
p. 99-105
|
artikel
|
| 6 |
Differential humoral responses against heat-shock proteins after autologous stem cell transplantation in multiple myeloma
|
Tovar, Natalia
|
|
2013
|
93 |
1 |
p. 107-111
|
artikel
|
| 7 |
Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML)
|
Tawfik, Bernard
|
|
2013
|
93 |
1 |
p. 47-55
|
artikel
|
| 8 |
EUTOS score predicts early optimal response to imatinib according to the revised 2013 ELN recommendations
|
Bonifacio, Massimiliano
|
|
2013
|
93 |
1 |
p. 163-164
|
artikel
|
| 9 |
Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?
|
Broek, E. C. van den
|
|
2013
|
93 |
1 |
p. 157-162
|
artikel
|
| 10 |
Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T cell leukemia: a risk of opportunistic infection after treatment with anti-CCR4 antibodies
|
Ohyama, Yasuyo
|
|
|
93 |
1 |
p. 169-171
|
artikel
|
| 11 |
Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T cell leukemia: a risk of opportunistic infection after treatment with anti-CCR4 antibodies
|
Ohyama, Yasuyo
|
|
2013
|
93 |
1 |
p. 169-171
|
artikel
|
| 12 |
Interferon alpha with or without rituximab achieves a high response rate and durable responses in relapsed FL: 17 years’ experience in a single centre
|
Radesi-Sarghi, Sinziana
|
|
2013
|
93 |
1 |
p. 147-156
|
artikel
|
| 13 |
Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes
|
Giagounidis, Aristoteles
|
|
2013
|
93 |
1 |
p. 1-11
|
artikel
|
| 14 |
Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea—experience from 110 patients
|
Kim, Kihyun
|
|
2013
|
93 |
1 |
p. 113-121
|
artikel
|
| 15 |
MtDNA depletion and deletions may also have a role in myelodysplastic syndrome
|
Cayci, Tuncer
|
|
2013
|
93 |
1 |
p. 179
|
artikel
|
| 16 |
Multiple myeloma: a descriptive study of 217 Egyptian patients
|
El Husseiny, Noha M.
|
|
2013
|
93 |
1 |
p. 141-145
|
artikel
|
| 17 |
No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation
|
Bertz, Hartmut
|
|
2013
|
93 |
1 |
p. 165-167
|
artikel
|
| 18 |
Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia
|
Martínez-Cuadrón, David
|
|
2013
|
93 |
1 |
p. 43-46
|
artikel
|
| 19 |
Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis
|
Machherndl-Spandl, Sigrid
|
|
2013
|
93 |
1 |
p. 57-64
|
artikel
|
| 20 |
Real life experience with alemtuzumab treatment of patients with lower-risk MDS and a hypocellular bone marrow
|
Neukirchen, Judith
|
|
2013
|
93 |
1 |
p. 65-69
|
artikel
|
| 21 |
“Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group
|
Katodritou, Eirini
|
|
2013
|
93 |
1 |
p. 129-139
|
artikel
|
| 22 |
The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis
|
Erben, Philipp
|
|
2013
|
93 |
1 |
p. 81-88
|
artikel
|
| 23 |
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea
|
Kim, Jin Seok
|
|
2013
|
93 |
1 |
p. 33-42
|
artikel
|
| 24 |
Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
|
Mousset, Sabine
|
|
2013
|
93 |
1 |
p. 13-32
|
artikel
|
| 25 |
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV
|
Kalmanti, Lida
|
|
2013
|
93 |
1 |
p. 71-80
|
artikel
|
Tijdschrift beschrijving